Emcure Pharmaceuticals has partnered with Gilead Sciences Ireland UC to manufacture and distribute generic lenacapavir for ...

Emcure Pharmaceuticals has partnered with Gilead Sciences to produce and distribute generic lenacapavir, an HIV treatment ...

Emcure Pharma’s "ACE YOUR HEART" awareness campaign enters Asia Book of Records on World Heart Day: Our Bureau, Mumbai Monday, September 30, 2024, 17:10 Hrs [IST] Emcure Pharmac ...

Gilead Sciences signs voluntary licensing agreement with six pharma firms to produce generic lenacapavir: Our Bureau, New Delhi Thursday, October 3, 2024, 11:30 Hrs [IST] US-based ...

Emcure Pharma stock price is up more than 19% from its listing price and over 56% from its IPO price. The pharma stock has ...

Indian pharmaceutical companies are set to produce generic versions of lenacapavir, an HIV prevention drug, under agreements ...

The U.S.-based drugmaker also plans to provide the companies branded version of the drug, lenacapavir, in 18 countries, such ...

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all ...

Emcure Pharmaceuticals share price jumped over 5% to hit a fresh 52-week high on Wednesday after domestic brokerage firm Kotak Institutional Equities initiated coverage on the stock with a bullish ...

Emcure Pharmaceuticals on Thursday said it has launched a product range aimed at supporting women through their menopausal journey. The Arth range of products addresses the challenges faced by ...

Kotak Institutional Equities noted that Emcure is one of the few Indian pharmaceutical majors with no direct exposure to the ...